Home・Aktien・Abbott Laboratories

Abbott Laboratories

Open

BrancheGesundheitswesen

107.92 2.19

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

104.62

Max

107.8

Schlüsselkennzahlen
By Trading Economics
Einkommen	-149M 928M
Verkäufe	1.4B 13B
KGV Branchendurchschnitt	34.667 68.51
EPS	1.31
Dividendenrendite	2.35
Gewinnspanne	7.369
Angestellte	122,000
EBITDA	-465M 1.8B

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+14.3% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	2.35% 2.29%
Nächstes Ergebnis	14. Okt. 2026
Nächste Dividendenausschüttung	17. Aug. 2026
Nächstes Ex-Dividendendatum	14. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	23B 187B
Vorheriger Eröffnungskurs	105.73
Vorheriger Schlusskurs	107.92

Nachrichtenstimmung

By Acuity

22%

78%

56 / 340 Ranking in Healthcare

Abbott Laboratories Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Abbott Laboratories Prognose

Kursziel

By TipRanks

14.3% Vorteil

12-Monats-Prognose

Durchschnitt 120.83 USD 14.3%

Hoch 135 USD

Tief 112 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Abbott Laboratories – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

15 ratings

Buy

Halten

Sell

Basierend auf 15 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Abbott Laboratories – Dist abgegeben haben.

Stimmung

By Acuity

56 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.